Patients treated with long-duration anti-platelet therapies after the placement of a drug-eluting stent showed lower rates of heart attack but higher rates of major bleeding events and a slight increase in mortality, according to a new study released today.
Sorin shareholders OK Cyberonics merger
Sorin Group (BIT:SRN) said shareholders met today and approved its upcoming merger with Cyberonics (NSDQ:CYBX). The deal, which is slated to bring together global leaders in neuromodulation and cardiac surgery with a combined equity value of $2.7 billion, is expected to close by the end of the 3rd quarter. Sorin stockowners will receive 0.0472 units of […]
Medtech engineer starts high-tech wine company Coravin
Medtech engineer and founder of Intrinsic Therapeutics George Lambrecht has formed Coravin, a high-tech wine company that produces a device for tapping wine bottles without removing the cork.
AirXpanders plans $28m IPO Down Under
Breast tissue expansion device maker AirXpanders said yesterday that it filed for an initial public offering in Australia, looking to raise $36.5 million Australian (about $28 million U.S.). Palo Alto, Calif.-based AirXpanders said it’s planning to float 73 million shares at A50¢ apiece. AirXpanders’ AeroForm tissue expander is designed for use in post-mastectomy breast reconstructions […]
Sync Project partners with Berklee College of Music
The Sync Project said it’s partnered with Berklee College of Music’s Institute for Creative Entrepreneurship as it explores the therapeutic effects of music.
HRS 2015: Boston Scientific, St. Jude Medical come out looking good
Lumicell receives FDA nod for feasibility trial
Lumicell Diagnostics said it won an investigational device exemption from the FDA for a pilot feasibility trial of its imaging system for breast cancer surgeries.
The study is slated to be conducted at the Mass. General Hospital in Boston, the company said.
Warburg Pincus takes majority stake in Sterigenics
Private equity firm Warburg Pincus acquired a majority stake in contact sterilization provider Sterigenics International, according to GTCR, which bought the company in 2011.
On-X Life Technologies launches mitral valve chord repair system
On-X Life Technologies said it’s launching Chord-X, a new mitral valve chordal repair system using the company’s proprietary sutures.